kynurenine has been researched along with Acute Onset Vascular Dementia in 1 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tohgi, H | 1 |
| Abe, T | 1 |
| Takahashi, S | 1 |
| Saheki, M | 1 |
| Kimura, M | 1 |
1 trial available for kynurenine and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor.
Topics: Aged; Alzheimer Disease; Citalopram; Dementia, Vascular; Humans; Indoles; Kynurenine; Selective Sero | 1995 |